NR1H4 and metabolic dysfunction-associated steatohepatitis: We found that treatment with the combination of geniposide and chlorogenic acid was able to alleviate NASH in a mouse model via improvement of the gut microbiota and activation of FXR signaling and that its effect was truly better than each individual agent alone.